z-logo
open-access-imgOpen Access
Different behaviour of DVL 1, DVL 2, DVL 3 in astrocytoma malignancy grades and their association to TCF 1 and LEF 1 upregulation
Author(s) -
Kafka Anja,
Bačić Mateja,
Tomas Davor,
Žarković Kamelija,
Bukovac Anja,
Njirić Niko,
Mrak Goran,
Krsnik Željka,
PećinaŠlaus Nives
Publication year - 2019
Publication title -
journal of cellular and molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.44
H-Index - 130
eISSN - 1582-4934
pISSN - 1582-1838
DOI - 10.1111/jcmm.13969
Subject(s) - microbiology and biotechnology , chemistry , biology
Key regulators of the Wnt signalling, DVL 1, DVL 2 and DVL 3, in astrocytomas of different malignancy grades were investigated. Markers for DVL 1 , DVL 2 and DVL 3 were used to detect microsatellite instability ( MSI ) and gross deletions ( LOH ), while immunohistochemistry and immunoreactivity score were used to determine the signal strengths of the three DVL proteins and transcription factors of the pathway, TCF 1 and LEF 1. Our findings demonstrated that MSI at all three DVL loci was constantly found across tumour grades with the highest number in grade II ( P  = 0.008). Collectively, LOH s were more frequent in high‐grade tumours than in low grade ones. LOH s of DVL 3 gene were significantly associated with grade IV tumours ( P  = 0.007). The results on protein expressions indicated that high‐grade tumours expressed less DVL 1 protein as compared with low grade ones. A significant negative correlation was established between DVL 1 expression and malignancy grades ( P  < 0.001). The expression of DVL 2 protein was found similar across grades, while DVL 3 expression significantly increased with malignancy grades ( P  < 0.001). The signal strengths of expressed DVL 1 and DVL 3 were negatively correlated ( P  = 0.002). However, TCF 1 and LEF 1 were both significantly upregulated and increasing with astrocytoma grades ( P  = 0.001). A positive correlation was established between DVL 3 and both TCF 1 ( P  = 0.020) and LEF 1 ( P  = 0.006) suggesting their joint involvement in malignant progression. Our findings suggest that DVL 1 and DVL 2 may be involved during early stages of the disease, while DVL 3 may have a role in later phases and together with TCF 1 and LEF 1 promotes the activation of Wnt signalling.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here